相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F. Docherty et al.
EUROPEAN HEART JOURNAL (2020)
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C. Petrie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
John J. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Heart Failure Is a Major Contributor to Hospital Readmission Penalties
Andrija Vidic et al.
JOURNAL OF CARDIAC FAILURE (2015)
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
Anne B. Curtis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Semiparametric regression for the mean and rate functions of recurrent events
DY Lin et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2000)
分享论文
